The following is a summary of “Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide ...

The SARS-CoV-2 Omicron (B.1.1.529) variant emerged in early November 2021 and its rapid spread created fear worldwide. This was attributed to its increased infectivity and escaping immune mechanisms.

Experts say the Omicron-derived XEC variant might soon take over as the dominant strain on the continent. Sharing insights ...

The complex and ever-evolving immunity landscape associated with SARS-CoV-2, combined with immune evasion by omicron ...

KP.3 was the 'predominant' SARS-CoV-2 variant in the US. It was also spreading in Europe. It's now joined with another ...

The US Centers for Disease Control and Prevention (CDC) last week in an update that it projects that vaccine manufacturers ...

There was a slightly higher risk for inflammatory bowel disease and blistering skin disorders only in hospitalized COVID-19 ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination ...

What are the new XEC COVID variant symptoms, and when will it hit the U.S.? Doctors explain what to watch for, and the best ...

First detected in Germany this June, the XEC variant is fast spreading across the world with infections recorded in 15 ...